Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/11837
Title: Evaluation of automated pediatric sleep stage classification using U-Sleep: a convolutional neural network
Authors: Kevat, A.;Steinkey, R.;Suresh, S. ;Ruehland, W. R.;Chawla, J.;Terrill, P. I.;Collaro, A. ;Iyer, K.
Issue Date: 2025
Source: J Clin Sleep Med, 2025 (21) 2 p.277-285
Pages: 277-285
Journal Title: J Clin Sleep Med
Abstract: STUDY OBJECTIVES: U-Sleep is a publicly available automated sleep stager, but has not been independently validated using pediatric data. We aimed to (1) test the hypothesis that U-Sleep performance is equivalent to trained humans, using a concordance dataset of 50 pediatric polysomnogram excerpts scored by multiple trained scorers, and (2) identify clinical and demographic characteristics that impact U-Sleep accuracy, using a clinical dataset of 3,114 polysomnograms from a tertiary center. METHODS: Agreement between U-Sleep and "gold" 30-second epoch sleep staging was determined across both datasets. Utilizing the concordance dataset, the hypothesis of equivalence between human scorers and U-Sleep was tested using a Wilcoxon 2 1-sided test. Multivariable regression and generalized additive modeling were used on the clinical dataset to estimate the effects of age, comorbidities, and polysomnographic findings on U-Sleep performance. RESULTS: The median (interquartile range) Cohen's kappa agreement of U-Sleep and individual trained humans relative to "gold" scoring for 5-stage sleep staging in the concordance dataset were similar, kappa = 0.79 (0.19) vs 0.78 (0.13), respectively, and satisfied statistical equivalence (2 1-sided test P < .01). Median (interquartile range) kappa agreement between U-Sleep 2.0 and clinical sleep-staging was kappa = 0.69 (0.22). Modeling indicated lower performance for children < 2 years, those with medical comorbidities possibly altering sleep electroencephalography (kappa reduction = 0.07-0.15) and those with decreased sleep efficiency or sleep-disordered breathing (kappa reduction = 0.1). CONCLUSIONS: While U-Sleep algorithms showed statistically equivalent performance to trained scorers, accuracy was lower in children < 2 years and those with sleep-disordered breathing or comorbidities affecting electroencephalography. U-Sleep is suitable for pediatric clinical utilization provided automated staging is followed by expert clinician review. CITATION: Kevat A, Steinkey R, Suresh S, et al. Evaluation of automated pediatric sleep stage classification using U-Sleep: a convolutional neural network. J Clin Sleep Med. 2025;21(2):277-285.
DOI: 10.5664/jcsm.11362
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications

Show full item record

Page view(s)

52
checked on Oct 8, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.